Bionime Competitors

4737 Stock  TWD 51.50  3.80  6.87%   
Bionime Corp competes with Icares Medicus, Maxigen Biotech, Medigen Biotechnology, Orient Europharma, and Senhwa Biosciences; as well as few others. The company operates under Health Care Equipment & Supplies sector and is part of Health Care industry. Analyzing Bionime Corp competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Bionime Corp to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Bionime Corp Correlation with its peers.

Bionime Corp vs Energenesis Biomedical Correlation

Very good diversification

The correlation between Bionime Corp and 6657 is -0.3 (i.e., Very good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Bionime Corp and 6657 in the same portfolio, assuming nothing else is changed.

Moving together with Bionime Stock

  0.642317 Hon Hai PrecisionPairCorr

Moving against Bionime Stock

  0.831303 Nan Ya PlasticsPairCorr
  0.762454 MediaTek Earnings Call This WeekPairCorr
  0.722882 Cathay Financial HoldingPairCorr
  0.712330 Taiwan SemiconductorPairCorr
  0.710050 YuantaP shares TaiwanPairCorr
Hype
Prediction
LowEstimatedHigh
49.8251.5053.18
Details
Intrinsic
Valuation
LowRealHigh
43.6845.3656.65
Details
Naive
Forecast
LowNextHigh
52.3954.0755.75
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
51.1255.1159.10
Details

Bionime Corp Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Bionime Corp and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Bionime and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Bionime Corp does not affect the price movement of the other competitor.

High positive correlations

31766794
66576492
41206612
64921783
41201752
67941783
  

High negative correlations

67941752
31761752
17831752
41206794
67946612
41203176

Risk-Adjusted Indicators

There is a big difference between Bionime Stock performing well and Bionime Corp Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Bionime Corp's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Bionime Corp Competitive Analysis

The better you understand Bionime Corp competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Bionime Corp's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Bionime Corp's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
4737 6612 1752 1783 6794 6748 3176 4120 6492 6657
 6.87 
 51.50 
Bionime
 0.97 
 81.80 
Icares
 1.49 
 36.40 
Nang
 1.07 
 46.20 
Maxigen
 0.90 
 88.50 
UnicoCell
 0.66 
 60.00 
ACRO
 0.30 
 32.75 
Medigen
 0.56 
 45.10 
Orient
 1.02 
 59.60 
Senhwa
 8.42 
 51.10 
Energenesis
Market Volatility
(90 Days Market Risk)
Market Performance
(90 Days Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Current Ratio
Net Asset
Profit Margin
EBITDA
Operating Margin
Current Valuation
Price To Book
Retained Earnings
Current Asset
Five Year Return
Beta
Number Of Employees
Shares Outstanding
Cash Flow From Operations
Annual Yield
Total Debt
Return On Equity
Z Score
Return On Asset
Book Value Per Share
Current Liabilities
Total Asset
Debt To Equity
Target Price
Last Dividend Paid
Shares Owned By Institutions
Market Capitalization
Price To Earning
Price To Sales
Net Income
Earnings Per Share
Shares Owned By Insiders
Revenue
Working Capital
Cash And Equivalents
Cash Per Share
Gross Profit
Day Typical Price
Accumulation Distribution
Market Facilitation Index
Daily Balance Of Power
Period Momentum Indicator
Rate Of Daily Change
Day Median Price
Price Action Indicator
Relative Strength Index
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Sortino Ratio
Downside Variance
Standard Deviation
Kurtosis
Potential Upside
Treynor Ratio
Maximum Drawdown
Variance
Market Risk Adjusted Performance
Risk Adjusted Performance
Skewness
Semi Deviation
Information Ratio
Value At Risk
Expected Short fall
Downside Deviation
Semi Variance

Bionime Corp Competition Performance Charts

Five steps to successful analysis of Bionime Corp Competition

Bionime Corp's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Bionime Corp in relation to its competition. Bionime Corp's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Bionime Corp in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Bionime Corp's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Bionime Corp, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Bionime Corp position

In addition to having Bionime Corp in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Alcohol Thematic Idea Now

Alcohol
Alcohol Theme
Companies involved in production and distribution of wines and alcoholic beverages. The Alcohol theme has 18 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Alcohol Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Bionime Stock Analysis

When running Bionime Corp's price analysis, check to measure Bionime Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bionime Corp is operating at the current time. Most of Bionime Corp's value examination focuses on studying past and present price action to predict the probability of Bionime Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bionime Corp's price. Additionally, you may evaluate how the addition of Bionime Corp to your portfolios can decrease your overall portfolio volatility.